COVID-19: Review of Epidemiology and Potential Treatments Against 2019 Novel Coronavirus
Open Access
- 26 April 2020
- journal article
- review article
- Published by Applied Systems, srl in Discoveries
- Vol. 8 (2) , e108
Abstract
An epidemic of extreme respiratory deterrence, pneumonia and shortness of breath, the SARS-CoV-2 viral infection began in Wuhan, Hubei Province, China in December 2019, and rapidly spread across China and beyond, with human to human transmission. On February 12, 2020, World Health Organization officially named the new coronavirus disease as coronavirus disease 19 (COVID-19). Most COVID-19 patients were diagnosed with pneumonia and many were treated using Chinese medicines and other secondary therapies. As of April 22, 2020, the total figure of infected patients has crossed 2.6 million people worldwide with over 180,000 deaths and 700,000 patients that have recovered. Preliminary reports suggest that certain drugs, such as chloroquine and antiviral nucleotide analogues such as remdesivir, which inhibit viral replication, can target the new coronavirus, although their usefulness in the clinic is still under debate. An expert US committee developed the US NIH guidelines for COVID-19 treatment, which was just released and will be regularly updated. This manuscript reviews the epidemiology, etiology, mortality, COVID-19 clinical symptoms, and potential therapeutic drugs, while highlighting the seriousness and damage-induced by SARS-CoV-2.Keywords
This publication has 57 references indexed in Scilit:
- Ethical and legal framework and regulation for off-label use: European perspectiveTherapeutics and Clinical Risk Management, 2014
- Anti-malaria drug chloroquine is highly effective in treating avian influenza A H5N1 virus infection in an animal modelCell Research, 2012
- Inhibition of hepatitis C virus replication by chloroquine targeting virus-associated autophagyJournal of Gastroenterology, 2009
- Architecture of the SARS coronavirus prefusion spikeNature Structural & Molecular Biology, 2006
- New insights into the antiviral effects of chloroquineThe Lancet Infectious Diseases, 2006
- Chinese Herbal Medicine for Severe Acute Respiratory Syndrome: A Systematic Review and Meta-AnalysisThe Journal of Alternative and Complementary Medicine, 2004
- Inhibition of Human Immunodeficiency Virus Infectivity by ChloroquineAIDS Research and Human Retroviruses, 1990
- Diagnosis of Chloroquine Cardiomyopathy by Endomyocardial BiopsyNew England Journal of Medicine, 1987
- Ammonium chloride and chloroquine inhibit rabies virus infection in neuroblastoma cellsArchives of Virology, 1984
- Hygiene and Preventive Medicine in Ancient ChinaJournal of the History of Medicine and Allied Sciences, 1962